Serum Immune-Inflammation Index Assessment in the Patients with Ulcerative Colitis

Table 1

Comparison of demographic, colonoscopic, and laboratory findings between the patients with active ulcerative colitis and ulcerative colitis in remission.

	Patients with active UC	Patients with UC in remission
Age (year)			0.379
Sex (F/M)	25/22	17/17	0.477
Site of involvement			0.85
Left-sided	22	22
Extensive	25	12
Treatment
None	3	0	0.26
5-ASA	30	23	0.815
Azatiopurine	10	11	0.309
Steroid	4	0	0.135
Mayo subscore			<0.001
0	0	34
1	17	0
2	18	0
3	12	0

UC: ulcerative colitis; ASA: acetylsalicylic acid.